Get started
BBB

BIO VITOS PHARMA AB

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

BIOVIT chart


Full chart

Key stats


Market capitalization
‪26.87 M‬ SEK
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.636 SEK
Net income (FY)
‪−12.87 M‬ SEK
Revenue (FY)
‪3.00 M‬ SEK
Shares float
—
Beta (1Y)
−0.23

About BIO VITOS PHARMA AB


Sector
Health Technology
Industry
Medical Specialties
CEO
Jon Jesper Birgemo
Website
hemcheck.se
Headquarters
Solna
Founded
2010
ISIN
SE0023286919
FIGI
BBG00G6RXWX5
Bio Vitos Pharma AB is a medical technology company. It engages in the business of producing and developing a concept for point-of-care detection of hemolysis in blood samples. The company was founded by Anders Mathias Karlsson and Per Hjalmar Olof Didrikson in 2010 and is headquartered in Solna, Sweden.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BIOVIT news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BIOVIT is 0.670 SEK — it has decreased by −1.76% in the past 24 hours. Watch BIO VITOS PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIO VITOS PHARMA AB stocks are traded under the ticker BIOVIT.
BIOVIT stock has fallen by −33.00% compared to the previous week, the month change is a −48.46% fall, over the last year BIO VITOS PHARMA AB has showed a −70.22% decrease.
BIOVIT reached its all-time high on Aug 1, 2024 with the price of 6.950 SEK, and its all-time low was 0.670 SEK and was reached on Nov 7, 2024. View more price dynamics on BIOVIT chart.
See other stocks reaching their highest and lowest prices.
BIOVIT stock is 2.10% volatile and has beta coefficient of −0.23. Track BIO VITOS PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is BIO VITOS PHARMA AB there?
Today BIO VITOS PHARMA AB has the market capitalization of ‪26.87 M‬, it has decreased by −36.19% over the last week.
Yes, you can track BIO VITOS PHARMA AB financials in yearly and quarterly reports right on TradingView.
BIOVIT net income for the last quarter is ‪−3.16 M‬ SEK, while the quarter before that showed ‪−3.15 M‬ SEK of net income which accounts for −0.27% change. Track more BIO VITOS PHARMA AB financial stats to get the full picture.
No, BIOVIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO VITOS PHARMA AB EBITDA is ‪−4.95 M‬ SEK, and current EBITDA margin is −410.88%. See more stats in BIO VITOS PHARMA AB financial statements.
Like other stocks, BIOVIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO VITOS PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO VITOS PHARMA AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO VITOS PHARMA AB stock shows the neutral signal. See more of BIO VITOS PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.